comparemela.com

Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea

Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

South Korea ,Ukraine ,Russia ,Japan ,New York ,United States ,Tokyo ,China ,California ,San Francisco ,South Korean ,Japanese ,South Koreans ,Catalys Pacific ,Hepalys Pharma ,Aude Lepreux ,Nonliver Comorbidities ,Pascaline Clerc ,Exchange Commission On ,Mitsubishi Ufj ,Nasdaq ,Innovation Fund ,Hepalys Pharma Inc We ,Global External Affairs ,Brunswick Group ,Patricial Bank ,Hepalys Pharma Inc ,Long Island City ,Euronext Paris ,Greater China ,Representative Director ,Breakthrough Therapy ,Fast Track ,Nasdaq Global Market ,Global External ,Roquet Montegon ,Private Securities Litigation Reform Act ,New Drug Application ,Universal Registration Document ,Des March ,Annual Report ,Exchange Commission ,Liver Fibrosis Prevalence ,Metabolic Comorbidities ,

comparemela.com © 2020. All Rights Reserved.